The use case: how Converge deploys Nebius AI Cloud
Converge Bio trained Converge-SC, a transformer-based foundation model for single-cell RNA sequencing data, on Nebius AI infrastructure. The model processes the full transcriptome of each cell and supports patient-level analysis for drug discovery and clinical development.
Nebius AI Cloud users in Biotech & Pharma
Companies in the same sector, with public evidence.
See all Nebius AI Cloud customersGo straight to the source
Based on Nebius AI Cloud’s published case study. We check the public evidence; the results are reported by the vendor.
nebius.com- Last checked
- Nov 20, 2026
Open source capture What the story claims, and what we checked
What we compared with the page.
- The passage quoted aboveChecked
Copied word for word from the page, near the name of Converge.
- Converge uses Nebius AI CloudChecked
Confirmed line.
- The result itselfNot checked
We quote it; we did not measure it.
With Nebius’ AI-native infrastructure, they’ve trained a full-transcriptome foundation model (Converge-SC) capable of processing 20,000+ genes per cell — delivering state-of-the-art accuracy, explainability and speed for drug discovery and clinical development.




